The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review
暂无分享,去创建一个
[1] Michael Wall,et al. Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial , 2002, Multiple sclerosis.
[2] J A Helpern,et al. Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.
[3] J. Ranjeva,et al. Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study , 2008, Multiple sclerosis.
[4] A. Dale,et al. Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach , 1993, Journal of Cognitive Neuroscience.
[5] A J Thompson,et al. Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[6] Wei-yan Zhang,et al. Prognostic value of magnetic resonance imaging in patients with clinically isolated syndrome conversion to multiple sclerosis: a meta-analysis. , 2013, Neurology India.
[7] R. Kinkel,et al. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. , 2012, Archives of neurology.
[8] M. Filippi,et al. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes , 2005, The Lancet Neurology.
[9] C. Enzinger,et al. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome , 2011, Multiple sclerosis.
[10] A. Thompson,et al. Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI , 2001, Journal of neurology, neurosurgery, and psychiatry.
[11] F. Barkhof,et al. MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome , 2009, BMC neurology.
[12] Jeffrey A. Cohen,et al. Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy , 2002, Multiple sclerosis.
[13] M. Ron,et al. Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[14] A. Thompson,et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.
[15] Mark W. Woolrich,et al. Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.
[16] I. Moseley,et al. Multisequence MRI in clinically isolated syndromes and the early development of MS , 1999, Neurology.
[17] Hans Lassmann,et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.
[18] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[19] Michael Wall,et al. MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group , 2002, Neurology.
[20] G. Comi,et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS , 2008, Journal of Neurology.
[21] Donald H. Lee,et al. Increased deep gray matter iron is present in clinically isolated syndromes. , 2014, Multiple sclerosis and related disorders.
[22] Marco Rovaris,et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. , 2009, Archives of neurology.
[23] R. Alroughani,et al. Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria , 2012, ISRN neurology.
[24] R. Henry,et al. Regional grey matter atrophy in clinically isolated syndromes at presentation , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[25] S Ropele,et al. Determinants of brain iron in multiple sclerosis , 2011, Neurology.
[26] Rohit Bakshi,et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2010, Multiple sclerosis.
[27] G. Barker,et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS , 2002, Neurology.
[28] H. McFarland,et al. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis , 1995, Multiple sclerosis.
[29] Anders M. Dale,et al. Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.
[30] M. Calabrese,et al. The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.
[31] Jeffrey A. Cohen,et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.
[32] M. Dwyer,et al. Thalamic atrophy is associated with development of clinically definite multiple sclerosis. , 2013, Radiology.
[33] M. Dwyer,et al. Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy , 2012, American Journal of Neuroradiology.
[34] S Ropele,et al. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis , 2011, Multiple sclerosis.
[35] G. Comi,et al. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. , 2000, AJNR. American journal of neuroradiology.
[36] A. Thompson,et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.
[37] C. Beaulieu,et al. Determinants of anisotropic water diffusion in nerves , 1994, Magnetic resonance in medicine.
[38] M. Battaglini,et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.
[39] Maria Assunta Rocca,et al. A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2005, NeuroImage.
[40] C. Pozzilli,et al. The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis , 2004, Journal of Neurology.
[41] Ludwig Kappos,et al. Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. , 2007, Archives of neurology.
[42] Margit Jehna,et al. Quantitative susceptibility mapping in multiple sclerosis. , 2013, Radiology.
[43] M. Filippi,et al. Simple and complex movement‐associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis , 2004, Human brain mapping.
[44] Dana Horakova,et al. Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study , 2012, PloS one.
[45] H. Schild,et al. Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy , 2007, American Journal of Neuroradiology.
[46] F. Barkhof,et al. A three-year, multi-parametric MRI study in patients at presentation with CIS , 2008, Journal of Neurology.
[47] M. Filippi,et al. A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. , 2005, AJNR. American journal of neuroradiology.
[48] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[49] R. Kinkel,et al. Bimonthly cranial MRI activity following an isolated monosymptomatic demyelinating syndrome: potential outcome measures for future multiple sclerosis `prevention' trials , 1999, Multiple sclerosis.
[50] Minna Raunio,et al. Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study , 2011, Journal of Neuroimmunology.
[51] C. Polman,et al. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. , 2004, Archives of neurology.
[52] M. Dwyer,et al. Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis , 2012, American Journal of Neuroradiology.
[53] J. Ranjeva,et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/MRSI study of corpus callosum , 2007, Multiple sclerosis.
[54] Daniel Rueckert,et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.
[55] Chunshui Yu,et al. Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI , 2012, Acta radiologica.
[56] F. Barkhof,et al. Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b , 2008, Journal of Neurology.
[57] E. Cristiano,et al. Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes , 2013, Multiple sclerosis.
[58] H P Hartung,et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.
[59] F. Bouwman,et al. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis , 2009, Neurology.
[60] M. Filippi,et al. Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis , 2011, Multiple sclerosis.
[61] Massimo Filippi,et al. Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. , 2010, Radiology.
[62] David H. Miller,et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2002, Annals of neurology.
[63] H. Schild,et al. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis , 2008, Neuroradiology.
[64] G. Barker,et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis , 1999, Journal of the Neurological Sciences.
[65] Carlo Pozzilli,et al. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. , 2002, Magnetic resonance imaging.
[66] M. Battaglini,et al. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis , 2011, Multiple sclerosis.
[67] Christian Confavreux,et al. Clinical outcomes assessment in multiple sclerosis , 1996, Annals of neurology.
[68] Nick C Fox,et al. Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.
[69] R. Hernández-Clares,et al. Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study. , 2013, Clinical therapeutics.
[70] Nicola De Stefano,et al. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS , 2009, Journal of the Neurological Sciences.
[71] Massimo Filippi,et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes , 2008, NeuroImage.
[72] Yunyun Duan,et al. Brain plasticity in relapsing–remitting multiple sclerosis: Evidence from resting-state fMRI , 2011, Journal of the Neurological Sciences.
[73] Gian Domenico Iannetti,et al. Cortical motor reorganization after a single clinical attack of multiple sclerosis. , 2002, Brain : a journal of neurology.
[74] Robert Zivadinov,et al. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis , 2007, NeuroImage.
[75] À. Rovira,et al. Brainstem lesions in clinically isolated syndromes , 2010, Neurology.
[76] Marco Bozzali,et al. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. , 2010, Radiology.
[77] Hompson,et al. A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .
[78] D. Louis Collins,et al. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis , 2010, NeuroImage.
[79] Marco Bozzali,et al. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. , 2010, Radiology.
[80] M. Filippo,et al. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[81] Ludwig Kappos,et al. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. , 2009, Archives of neurology.
[82] B. Thrower. Clinically isolated syndromes , 2007, Neurology.
[83] Derek K Jones,et al. Investigating exchange and multicomponent relaxation in fully‐balanced steady‐state free precession imaging , 2008, Journal of magnetic resonance imaging : JMRI.
[84] S Ropele,et al. Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.
[85] G J Barker,et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. , 2005, Brain : a journal of neurology.
[86] À. Rovira,et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes , 2006, Neurology.
[87] P. Pasqualetti,et al. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome , 2005, Multiple sclerosis.
[88] M. Rovaris,et al. A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2007, Journal of Neurology.
[89] P. Matthews,et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.
[90] J. De Keyser,et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.
[91] M. Battaglini,et al. Evaluating and reducing the impact of white matter lesions on brain volume measurements , 2012, Human brain mapping.
[92] G. Johnson,et al. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis , 2009, Journal of the Neurological Sciences.
[93] M. Filippi,et al. Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. , 2011, Radiology.
[94] Yunyun Duan,et al. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. , 2008, European journal of radiology.
[95] A. Janssens,et al. Callosal lesion predicts future attacks after clinically isolated syndrome , 2009, Neurology.
[96] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[97] A J Thompson,et al. Texture analysis of magnetization transfer maps from patients with clinically isolated syndrome and multiple sclerosis , 2009, Journal of magnetic resonance imaging : JMRI.
[98] Brian K. Rutt,et al. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI , 2012, NeuroImage.
[99] G. B. Pike,et al. Pulsed magnetization transfer contrast in gradient echo imaging: A two‐pool analytic description of signal response , 1996, Magnetic resonance in medicine.